BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21606645)

  • 1. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy.
    Asanuma K; Akiba-Takagi M; Kodama F; Asao R; Nagai Y; Lydia A; Fukuda H; Tanaka E; Shibata T; Takahara H; Hidaka T; Asanuma E; Kominami E; Ueno T; Tomino Y
    Am J Nephrol; 2011; 33(6):537-49. PubMed ID: 21606645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy.
    Kodama F; Asanuma K; Takagi M; Hidaka T; Asanuma E; Fukuda H; Seki T; Takeda Y; Hosoe-Nagai Y; Asao R; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2013 Jul; 28(7):1762-72. PubMed ID: 23143340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
    Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWC1 promotes podocyte survival via stabilizing slit diaphragm protein dendrin.
    Lin T; Zhang L; Liu S; Chen Y; Zhang H; Zhao X; Li R; Zhang Q; Liao R; Huang Z; Zhang B; Wang W; Liang X; Shi W
    Mol Med Rep; 2017 Dec; 16(6):8685-8690. PubMed ID: 28990091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendrin expression in glomerulogenesis and in human minimal change nephrotic syndrome.
    Dunér F; Patrakka J; Xiao Z; Larsson J; Vlamis-Gardikas A; Pettersson E; Tryggvason K; Hultenby K; Wernerson A
    Nephrol Dial Transplant; 2008 Aug; 23(8):2504-11. PubMed ID: 18356187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.
    Lydia A; Asanuma K; Nonaka K; Takagi M; Jeong KH; Kodama F; Asao R; Asanuma E; Prodjosudjadi W; Tomino Y
    Am J Nephrol; 2012; 35(1):58-68. PubMed ID: 22189044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
    Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
    BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerulosclerosis Induced by Deficiency of Membrane-Associated Guanylate Kinase Inverted 2 in Kidney Podocytes.
    Shirata N; Ihara KI; Yamamoto-Nonaka K; Seki T; Makino SI; Oliva Trejo JA; Miyake T; Yamada H; Campbell KN; Nakagawa T; Mori K; Yanagita M; Mundel P; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2017 Sep; 28(9):2654-2669. PubMed ID: 28539383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
    Mizdrak M; Vukojević K; Filipović N; Čapkun V; Benzon B; Durdov MG
    Diagn Pathol; 2018 Nov; 13(1):90. PubMed ID: 30458823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.
    Macconi D; Bonomelli M; Benigni A; Plati T; Sangalli F; Longaretti L; Conti S; Kawachi H; Hill P; Remuzzi G; Remuzzi A
    Am J Pathol; 2006 Jan; 168(1):42-54. PubMed ID: 16400008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.
    El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M
    J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes.
    Asanuma K; Campbell KN; Kim K; Faul C; Mundel P
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10134-9. PubMed ID: 17537921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
    Miyauchi N; Saito A; Karasawa T; Harita Y; Suzuki K; Koike H; Han GD; Shimizu F; Kawachi H
    J Am Soc Nephrol; 2006 Oct; 17(10):2748-59. PubMed ID: 16943307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.
    Liu S; Shi W; Xiao H; Liang X; Deng C; Ye Z; Mei P; Wang S; Liu X; Shan Z; Liang Y; Zhang B; Wang W; Liu Y; Xu L; Xia Y; Ma J; Li Z
    PLoS One; 2012; 7(7):e41331. PubMed ID: 22848465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.